SK18222001A3 - Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents

Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje Download PDF

Info

Publication number
SK18222001A3
SK18222001A3 SK1822-2001A SK18222001A SK18222001A3 SK 18222001 A3 SK18222001 A3 SK 18222001A3 SK 18222001 A SK18222001 A SK 18222001A SK 18222001 A3 SK18222001 A3 SK 18222001A3
Authority
SK
Slovakia
Prior art keywords
formula
group
pyrimidin
chloro
acid
Prior art date
Application number
SK1822-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Rochus Jonas
Pierre Schelling
Franz-Werner Kluxen
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK18222001A3 publication Critical patent/SK18222001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1822-2001A 1999-06-19 2000-06-07 Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje SK18222001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19928146A DE19928146A1 (de) 1999-06-19 1999-06-19 Thienopyrimidine
PCT/EP2000/005278 WO2000078767A1 (de) 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer

Publications (1)

Publication Number Publication Date
SK18222001A3 true SK18222001A3 (sk) 2002-06-04

Family

ID=7911858

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1822-2001A SK18222001A3 (sk) 1999-06-19 2000-06-07 Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje

Country Status (24)

Country Link
US (1) US6787548B1 (pt)
EP (1) EP1189907B1 (pt)
JP (1) JP2003502429A (pt)
KR (1) KR20020010719A (pt)
CN (1) CN1144806C (pt)
AR (1) AR024380A1 (pt)
AT (1) ATE285412T1 (pt)
AU (1) AU767273B2 (pt)
BR (1) BR0011778A (pt)
CA (1) CA2375278A1 (pt)
CZ (1) CZ293901B6 (pt)
DE (2) DE19928146A1 (pt)
ES (1) ES2234613T3 (pt)
HK (1) HK1047434B (pt)
HU (1) HUP0201730A3 (pt)
MX (1) MXPA01013228A (pt)
NO (1) NO20016201L (pt)
PL (1) PL351822A1 (pt)
PT (1) PT1189907E (pt)
RU (1) RU2238274C2 (pt)
SK (1) SK18222001A3 (pt)
UA (1) UA72256C2 (pt)
WO (1) WO2000078767A1 (pt)
ZA (1) ZA200200440B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
WO2003035653A1 (fr) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Compose pyridothienopyrimidine et son sel
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
RU2238274C2 (ru) 2004-10-20
UA72256C2 (uk) 2005-02-15
WO2000078767A1 (de) 2000-12-28
CN1355805A (zh) 2002-06-26
US6787548B1 (en) 2004-09-07
EP1189907A1 (de) 2002-03-27
EP1189907B1 (de) 2004-12-22
CZ20014422A3 (cs) 2002-03-13
CN1144806C (zh) 2004-04-07
DE19928146A1 (de) 2000-12-21
PT1189907E (pt) 2005-05-31
DE50009042D1 (en) 2005-01-27
ZA200200440B (en) 2003-06-25
CA2375278A1 (en) 2000-12-28
ATE285412T1 (de) 2005-01-15
AR024380A1 (es) 2002-10-02
PL351822A1 (en) 2003-06-16
HK1047434B (zh) 2005-01-28
BR0011778A (pt) 2002-04-23
ES2234613T3 (es) 2005-07-01
NO20016201D0 (no) 2001-12-18
AU767273B2 (en) 2003-11-06
JP2003502429A (ja) 2003-01-21
MXPA01013228A (es) 2002-07-02
HK1047434A1 (en) 2003-02-21
AU5220400A (en) 2001-01-09
NO20016201L (no) 2001-12-18
KR20020010719A (ko) 2002-02-04
HUP0201730A2 (en) 2002-09-28
HUP0201730A3 (en) 2004-12-28
CZ293901B6 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
US6420368B1 (en) Thienopyrimidines
SK7352003A3 (en) Use of thienopyrimidines
SK18222001A3 (sk) Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
SK15972000A3 (sk) Derivát kondenzovaného tienopyrimidínu s pde v inhibičným pôsobením, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
AU773878B2 (en) Pyrazolo(4,3-d)pyrimidines
US20040077664A1 (en) Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
SK7592003A3 (en) Use of pyrazolo[4,3-D]pyrimidines
US20040023991A1 (en) Use of pyrazolo[4,3-d]pyrimidines
SK3322002A3 (en) Use of thienopyrimidines
SK3372003A3 (en) Thienopyrimidine derivative, method for the preparation thereof and pharmaceutical composition comprising same
CZ2002817A3 (cs) Derivát aminu